Ligand profile
E4X
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_00958 — Ribonucleoside-diphosphate reductase 1 subunit alpha
Identifiers
Database identifiers and provenance.
- Ligand ID
E4X- PDB
6l3r- UniProt (similar protein)
P23921- Target protein
- KP13_00958
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 105.1
- −1 ≤ LogP ≤ 5 4.10
- MW ≤ 500 Da 488.4
- LogP ≤ 5 4.10
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 6
- TPSA ≤ 140 Ų 105.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
C[C@H](c1cccc2c1cccc2)[C@@H](C3=NNC(=O)O3)NS(=O)(=O)c4ccc(cc4)BrC[C@H](c1cccc2c1cccc2)[C@@H](C3=NNC(=O)O3)NS(=O)(=O)c4ccc(cc4)Br
InChI=1S/C21H18BrN3O4S/c1-13(17-8-4-6-14-5-2-3-7-18(14)17)19(20-23-24-21(26)29-20)25-30(27,28)16-11-9-15(22)10-12-16/h2-13,19,25H,1H3,(H,24,26)/t13-,19+/m1/s1InChI=1S/C21H18BrN3O4S/c1-13(17-8-4-6-14-5-2-3-7-18(14)17)19(20-23-24-21(26)29-20)25-30(27,28)16-11-9-15(22)10-12-16/h2-13,19,25H,1H3,(H,24,26)/t13-,19+/m1/s1
RXRDLPNXTGZSLC-YJYMSZOUSA-NRXRDLPNXTGZSLC-YJYMSZOUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF02867
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand E4X →
- PDB RCSB structure 6l3r →
- UniProt UniProt P23921 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “E4X”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_00958.
PDB 15
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 9
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).